NQVAX vs. SHXPX
NQVAX (Nuveen Multi-Cap Value Fund Class A) and SHXPX (American Beacon Shapiro Equity Opportunities Fund) are both Large Cap Value Equities funds. At a correlation of -0.40, they often move in opposite directions. NQVAX charges 1.15%/yr vs 1.21%/yr for SHXPX.
Performance
NQVAX vs. SHXPX - Performance Comparison
Loading charts...
Returns By Period
NQVAX
- 1D
- -0.69%
- 1M
- -0.34%
- YTD
- 12.48%
- 6M
- 13.16%
- 1Y
- 31.74%
- 3Y*
- 19.70%
- 5Y*
- 12.32%
- 10Y*
- 12.58%
SHXPX
- 1D
- -0.13%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NQVAX vs. SHXPX - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
NQVAX Nuveen Multi-Cap Value Fund Class A | -1.61% |
SHXPX American Beacon Shapiro Equity Opportunities Fund | 0.32% |
Correlation
The correlation between NQVAX and SHXPX is -0.40, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since May 29, 2026 | -0.40 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NQVAX vs. SHXPX — Risk / Return Rank
NQVAX
SHXPX
NQVAX vs. SHXPX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuveen Multi-Cap Value Fund Class A (NQVAX) and American Beacon Shapiro Equity Opportunities Fund (SHXPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NQVAX | SHXPX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.42 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 4.22 | — | — |
| Martin ratioReturn relative to average drawdown | 16.15 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NQVAX | SHXPX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.41 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.76 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.66 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 8.85 | -8.40 |
Drawdowns
NQVAX vs. SHXPX - Drawdown Comparison
The maximum NQVAX drawdown since its inception was -67.90%, which is greater than SHXPX's maximum drawdown of -0.13%. Use the drawdown chart below to compare losses from any high point for NQVAX and SHXPX.
Loading charts...
Drawdown Indicators
| NQVAX | SHXPX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.90% | -0.13% | -67.77% |
Max Drawdown (1Y)Largest decline over 1 year | -7.41% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -18.01% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -18.01% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -42.29% | — | — |
Current DrawdownCurrent decline from peak | -1.90% | -0.13% | -1.77% |
Average DrawdownAverage peak-to-trough decline | -11.81% | -0.03% | -11.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.93% | — | — |
Volatility
NQVAX vs. SHXPX - Volatility Comparison
Loading charts...
Volatility by Period
| NQVAX | SHXPX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.36% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 9.87% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 13.03% | 2.95% | +10.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.25% | 2.95% | +13.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.10% | 2.95% | +16.15% |
NQVAX vs. SHXPX - Expense Ratio Comparison
NQVAX has a 1.15% expense ratio, which is lower than SHXPX's 1.21% expense ratio.
Dividends
NQVAX vs. SHXPX - Dividend Comparison
NQVAX's dividend yield for the trailing twelve months is around 1.47%, while SHXPX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NQVAX Nuveen Multi-Cap Value Fund Class A | 1.47% | 1.66% | 1.62% | 1.06% | 1.17% | 1.23% | 3.17% | 1.10% | 0.00% | 1.76% | 0.79% | 0.78% |
SHXPX American Beacon Shapiro Equity Opportunities Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NQVAX and SHXPX have a correlation of -0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NQVAX and SHXPX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer